Quoin Pharmaceuticals (QNRX) Notes Payables (2020 - 2023)

Quoin Pharmaceuticals has disclosed Notes Payables across 4 years of filings, most recently posting $4.0 million for Q1 2023.

• In Q1 2023, Notes Payables changed N/A year-over-year to $4.0 million; the TTM figure through Mar 2023 stood at $4.0 million (changed N/A YoY), while the FY2022 annual figure was $4.1 million, up 587.29% from the prior year.
• Notes Payables came in at $4.0 million for Q1 2023 at Quoin Pharmaceuticals, down from $4.1 million in the prior quarter.
• In the past five years, Notes Payables ranged from a high of $4.9 million in Q4 2020 to a low of $600000.0 in Q4 2021.
• Average Notes Payables over 4 years is $3.7 million, with a median of $4.2 million recorded in 2022.
• Year-over-year, Notes Payables tumbled 87.73% in 2021 and jumped 587.29% in 2022.
• Over 4 years, Notes Payables stood at $4.9 million in 2020, then plunged by 87.73% to $600000.0 in 2021, then jumped by 587.29% to $4.1 million in 2022, then fell by 2.42% to $4.0 million in 2023.
• Per Business Quant data, the three most recent Notes Payables figures were $4.0 million in Q1 2023, $4.1 million in Q4 2022, and $4.3 million in Q3 2022.